pharmadog

Jobs

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

News

when

Latest
Archive

by source

All Sources
Sources Page

Companies

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

Calendar

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

made by humans and a good dog

home
jobs
news
cal
search

Wilate · pharmadog

pharmadog
drugs
Wilate

drug

patient view →

save

(antihemophilic factor (human) + von willebrand factor complex (human))

Marketedupdated 2mo ago

by Octapharma USA Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Wilate

generic

(antihemophilic factor (human) + von willebrand factor complex (human))

indication

Hemophilia A (Factor VIII Deficiency)

phase

marketed

Data sources

ClinicalTrials.gov

last refreshed 2h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

Trials studying (antihemophilic factor (human) + von willebrand factor complex (human))

phase3Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Agecompletedn=12
—Von Willebrand Factor in Pregnancy (VIP) Studyrecruitingn=110
—Treatment of Hemophilia A Patients With FVIII Inhibitorsrecruitingn=120
—Effectiveness and Tolerability of Eqwilate in Real-life Conditionsactive not recruitingn=38
—Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiqterminatedn=14
phase3Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWDcompletedn=43